The Middle East and Africa GMP cytokines market is expected to reach US$ 5.61 million by 2027 from US$ 3.16 million in 2019; it is estimated to grow at a CAGR of 7.4% from 2020 to 2027.
The growth of the Middle East and Africa GMP cytokines market is attributed to key driving factors, such as increase in acceptance of cytokines for cancer and autoimmune therapies and potential contribution in stem cell therapy. However, high cost associated with GMP cytokines therapy is expected to obstruct the growth of the GMP Cytokines market to a certain extent during the forecast period.
Cytokines play a significant role in regulating innate and adaptive immunity, which enables cells of the immune system to communicate over short distances. The cytokines therapy to activate cancer patients' immune systems has been an essential parameter in the treatment. Several research activities have proved cytokines' ability to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines indirectly inhibit tumor growth by stimulating the cytotoxic activity of immune cells against tumor cells. Similarly, rising prevalence of autoimmune disorders is expected to impact the adoption of cytokines-based therapeutics positively. According to NCBI, a recent study published online in 2018, estimated that Rheumatoid Arthritis prevalence in the Middle East region is at 0.16%. This effectiveness of cytokines therapies over cancer and autoimmune disorders, coupled with increasing prevalence of the disease, is likely to drive the market by 2027. Additionally, increasing number of investments and collaborations by market players to develop cytokines therapies over chronic disorders are also expected to accelerate the market growth.
Middle East and Africa has been witnessing a growing number of COVID-19 cases since its outbreak. Cytokines play a significant role in the immune reaction to coronavirus infection. Some of the market players are also focusing on developing cytokine-based therapies to deal with COVID-19 pandemic. This factor is expected to positively impact the Middle East and Africa GMP cytokines market during the forecast period.
Middle East and Africa GMP Cytokines MarketRevenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe GMP Cytokines MarketSegmentation
By Type
- TNF
- Interleukin
- Growth Factor
- Others
By Application
- Cell and Gene Therapy
- Tissue-Engineered Products
- Others
By Country
- UAE
- Saudi Arabia
- South Africa
- Middle East and Africa
Company Profiles
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa GMP Cytokines Market – By Type
1.3.2 Middle East and Africa GMP Cytokines Market – By Application
1.3.3 Middle East and Africa GMP Cytokines market – By Country
2. GMP Cytokines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa GMP Cytokines – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa (MEA) – PEST Analysis
4.3 Expert Opinions
5. GMP Cytokines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
5.1.2 Potential Contribution in Stem Cell Therapy
5.2 Market Restraints
5.2.1 High Cost Associated with GMP Cytokines Therapy
5.3 Market Opportunities
5.3.1 Extensive Pipeline of Drug Candidates for Cytokines Therapeutics
5.4 Future Trends
5.4.1 Utilization of Cytokines as Biomarkers
5.5 Impact Analysis
6. GMP Cytokines Market – Middle East and Africa Analysis
6.1 Middle East and Africa GMP Cytokines Market Revenue Forecast and Analysis
7. GMP Cytokines Market Analysis – By Type
7.1 Overview
7.2 GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
7.3 TNF
7.3.1 Overview
7.3.2 TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Interleukin
7.4.1 Overview
7.4.2 Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Growth Factor
7.5.1 Overview
7.5.2 Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8. GMP Cytokines Market Analysis – By Application
8.1 Overview
8.2 GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
8.3 Cell and Gene Therapy
8.3.1 Overview
8.3.2 Cell and Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Tissue-Engineered Products
8.4.1 Overview
8.4.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9. GMP Cytokines Market – Middle East and Africa Analysis
9.1 Middle East & Africa: GMP Cytokines Market
9.1.1 Overview
9.1.2 Middle East & Africa: GMP Cytokines Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Middle East & Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.4 Middle East & Africa: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.5 Middle East & Africa: GMP Cytokines Market Share by Country – 2019 & 2027, (%)
9.1.6 Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Saudi Arabia: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.6.3 Saudi Arabia: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.7 UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UAE: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.7.3 UAE: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.8 South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9.1.8.1 South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 South Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.8.3 South Africa: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.9 Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9.1.9.1 Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Rest of Middle East and Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.9.3 Rest of Middle East and Africa: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Middle East and Africa GMP Cytokines Market
10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 ABCAM
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 PeproTech, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Akron Biotech
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 BIO-TECHNE CORPORATION
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 CREATIVE BIOARRAY
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Proteintech Group, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 REPROCELL, Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East & Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. Saudi Arabia GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. UAE GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. UAE GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. South Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. South Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Rest of Middle East and Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Rest of Middle East and Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Organic and Inorganic Developments Done by Companies
Table 12. Glossary of Terms, GMP Cytokines Market
LIST OF FIGURES
Figure 1. GMP Cytokines Market Segmentation
Figure 2. GMP Cytokines Market Segmentation, By Country
Figure 3. GMP Cytokines Market Overview
Figure 4. TNF Segment by Type Segment Expected to Witness Rapid Growth
Figure 5. Middle East and Africa GMP Cytokines Market – Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. GMP Cytokines Market Impact Analysis of Drivers and Restraints
Figure 8. Middle East and Africa GMP Cytokines Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
Figure 10. TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
Figure 15. Cell and Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Middle East & Africa: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)
Figure 19. Middle East & Africa GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)
Figure 20. Middle East & Africa: GMP Cytokines Market Share by Country – 2019 & 2027, (%)
Figure 21. Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Impact Of COVID-19 Pandemic in Middle East and Africa Market
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa GMP Cytokines Market
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2021